
About 85% of all instances of lung cancer are non-small cell lung cancer (NSCLC), making it the most common kind of the disease. It happens when aberrant cells proliferate in the lungs and cause tumors to grow. Compared to small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) is typically less aggressive and grows and spreads more slowly.
Type of Non-Small Cell Lung Cancer (NSCLC)
There are many types of NSCLC, including-
What is the Importance of Timely Treatment?
Timely treatment of Non-Small Cell Lung Cancer (NSCLC) is essential for several reasons:
Respiratory Symptoms
Chest Symptoms
General Symptoms
Causes
Risk Factors
India's increasing proficiency in precision medicine, immunotherapy, targeted medicines, and minimally invasive surgery has enhanced NSCLC diagnosis and treatment.
A novel approach to treating cancer is chimeric antigen receptor T-cell (CAR-T) therapy, which entails modifying T cells to have receptors intended to recognise and destroy tumor cells. Researchers are looking into possible targets for CAR-T therapy in NSCLC, such as mesothelin, EGFR, and PD-L1. Early results from preliminary clinical trials assessing the safety and efficacy of CAR-T cells in patients with non-small cell lung cancer are promising.
There are a few things you can do to lower your risk of developing Non-Small Cell Lung Cancer (NSCLC), particularly of the bladder, even if it is not always preventable:
Treatment options for NSCLC differ based on the type and stage of the disease and the patient's overall health. The following are a few current treatments:
Lobectomy: Elimination of a lung lobe. The most popular procedure for NSCLC in its early stages is this one.
Pneumonectomy: Removal of a lung in its whole. If the cancer is in an area of the lung where the entire organ needs to be removed, this procedure might be carried out.
Wedge Resection: This removes a little lung section with the tumor.
Segmentectomy: This is the Removal of a more prominent lung segment but not the entire lobe. Usually, this is applied to individuals with lung impairment or early-stage cancer.
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy. It may be used in combination with chemotherapy for Non-Small Cell Lung Cancer (NSCLC).
Targeted Therapy : Medication designed for particular forms of lung cancer is used in this treatment. Targeted therapy can locate and target specific cancer cells without endangering healthy cells.
Cost Start From USD 8000 - USD 12000Explore Options
Immunotherapy : This is typically advised for late-stage lung cancer, notably Stage IV NSCLC, as it triggers your body's immune system to target and eliminate cancer cells.
Cost Start From USD 3000 - USD 5000Explore Options
Chemotherapy : It uses medications that target lung cancer. It is among the most widely used therapies for NSCLC. Chemotherapy may be prescribed by your oncologist alone or in conjunction with other treatments.
Cost Start From USD 600 - USD 700Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
Laboratory Tests
MediRehab (chain of Rehab centres - Part of MediGence) provides comprehensive rehabilitation services designed to support NSCLC patients in India. These services include:
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Gurgaon, India
Millennium Cancer Center is a first of its kind medical center for the research & treatment of cancer in India. The center aims at promoting a knowledge-based cancer care system backed with the latest cancer screening and treatment technology. It provides affordable, accurate, and accessible healthcare to all groups of the society. The hospital has an excellent team of doctors with amazing services, unique infrastructure of international standards in services.
Infrastructure & Facilities:

Delhi, India
Max Super Speciality Hospital, Patparganj, a 400+ bed NABH-accredited facility under Balaji Medical and Diagnostic Research Centre, offers world-class care across 33+ specialties, including Cardiac Sciences, Oncology, Neurosciences, Orthopaedics, Obstetrics & Gynaecology, and Kidney Transplant. With 116 ICU beds, 14 HDU beds, 11 modular OTs, and an NABL-accredited Max Lab, the hospital ensures advanced, quality-driven care. Staffed by 510+ expert doctors and 770+ nurses, it’s India’s first AACI-accredited super speciality hospital and North & West India’s first QAI-accredited Advanced Brain Stroke Centre. Max Patparganj is a regional leader in complex surgeries, blending cutting-edge technology with compassionate, patient-centric healthcare.

Faridabad, India
Marengo Asia Hospitals, located in Faridabad, is a multispecialty, state-of-the-art, and patient-friendly facility that combines the greatest services available in the healthcare segment. With 325 beds now, the hospital can accommodate up to 550 beds. It has first-rate medical facilities including a Critical Care Medicine department for patients with life-threatening conditions. Furthermore, our highly skilled medical staff and cutting-edge software system make us the perfect facility for patients from various backgrounds. We always aim to exceed expectations and are always looking for ways to boost our performance.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Depending on the cancer's stage and treatment strategy, NSCLC therapy success rates in India vary. The 5-year survival rate for early-stage non-small cell lung cancer (NSCLC) can reach 60% to 70% if the disease is identified early and treated surgically.
The type of treatment received determines how long it takes to recover from NSCLC in India. Patients usually spend five to seven days in the hospital following lung surgery, and it may take them two to three months to fully recover. Fatigue is one of the side effects of radiation and chemotherapy, and it sometimes takes patients one to two months to recover their strength.
In India, it is customary practice to get a second opinion. In India, a lot of hospitals and oncologists are willing to assess cases and offer second opinions on treatment strategies. One can:
Yes, MediGence offers a wide range of assistance to patients from other countries seeking treatment for non-small cell lung cancer. The majority of large hospitals offer specialised departments for international patients that help with accommodations, airport transfers, visa arrangements, and language translation. To ensure that overseas patients have a seamless and hassle-free experience throughout their treatment journey, these departments also assist with financial information, appointment scheduling, and post-treatment care.
For NSCLC patients in India, post-treatment care and follow-up options include routine imaging tests (such as CT or PET scans) to look for recurrence and blood tests to assess general health.
To enhance endurance and recover lung function, particularly following surgery or radiation therapy, patients also undertake pulmonary rehabilitation.
While psychological assistance and counseling are given to help deal with the emotional difficulties of cancer treatment, nutritional advice is offered to help manage weight and recovery.
The patient's general health, the stage of the cancer at diagnosis, and the efficacy of the treatment all affect the prognosis. Advanced treatment options and early discovery can increase survival rates.
Yes, even after a successful course of treatment, non-small cell lung cancer (NSCLC) might return. The type of treatment received, the patient's response to the treatment, and the stage of the cancer at diagnosis all affect the chance of recurrence.
Yes, NSCLC is among the most common forms of lung cancer in India, although it is still less common than other malignancies like colorectal or breast cancer. Overall, lung cancer is one of the most common cancers in India, with 80–85% of cases being NSCLC